Diagnostic study demonstrates highly sensitive detection of methylated SEPT9 in hepatocellular carcinoma plasma, highlighting a cost-effective tool for liver cancer diagnosis.
An innovative semi-nested PCR assay integrates ExBP technology with TaqMan probes to quantify mSEPT9 in HCC plasma, offering high sensitivity (0.001%), specificity, and cost-effective diagnostic utility.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: